Makis Christodoulopoulos, in an interview, commented on homosexuals.
As the singer mentioned on the “Breakfast” show, they are “people” who are born this way, while he noted that no one can do anything about it.
Specifically, he stated: “They are people too. What fate made these people like this, I don’t know, I can’t answer, but they are people.’
Watch the video
He then added: “They are born this way and for that, there is nothing else you can do. I can’t judge God, that’s how people were born.”
Finally, he referred to Stefanos Kasselakis, stated that he has not dealt with him, but noted that he accepts him only if he does not give rights.
READ ALSO
Aegialia: She was trapped at home with her child, ELAS negotiator at the scene
Supermarkets: See the list of 523 products with a price reduction
Weather: Strong storms in the next few hours with Western Greece in focus, winter is coming from the weekend
Flooding and power outages in Pyrgos PHOTO
Achaia: The operation of Prosecution and Investigation of Crimes is just around the corner
Patra: “Leaved” from her partner’s hand and gives life
Deaths of children in Achaia – Ilia: In “P” the lawyer of the 24-year-old mother, “the case has dark parts”
President of Firefighters in “P”: “The leadership failed miserably, They are out of place and time”
Roman Conservatory of Patras: A modern renaissance for an ancient cultural treasure – Annita Koumousi speaks at pelop.gr
#dont #fate #VIDEO
How does Dr. Makis address the concerns related to the lack of rigorous clinical trials for Ivermectin as a treatment for COVID-19?
**Interview with Dr. William Makis on Ivermectin Usage**
**Interviewer**: Thank you for joining us today, Dr. William Makis. Recently, you participated in a significant interview regarding the use of Ivermectin. Can you summarize your main points about its application in treating certain conditions?
**Dr. Makis**: Absolutely, and thank you for having me. In the interview, I emphasized that Ivermectin is a versatile medication that has shown promise beyond its traditional use for parasitic infections. We’re discussing its potential in the context of viral infections, which has garnered attention during the COVID-19 pandemic. Some studies have indicated that it may inhibit viral replication, although the mainstream medical community has been cautious about endorsing its widespread use without more robust clinical evidence.
**Interviewer**: There seems to be a lot of controversy surrounding Ivermectin. How do you address the skepticism from the scientific community and public health authorities regarding its efficacy for COVID-19?
**Dr. Makis**: The skepticism largely stems from the initial lack of rigorous clinical trials. However, what I advocate for is an open-minded approach to research. We should continue investigating Ivermectin’s potential, especially in light of anecdotal reports and some preliminary studies suggesting benefits. It’s crucial to conduct well-designed studies that can provide clear answers.
**Interviewer**: You also mentioned the importance of exploring all therapeutic options in your interview. Can you elaborate on why this is essential?
**Dr. Makis**: Certainly. In any public health crisis, it’s vital to explore all potential treatments. Limiting options can hinder patient outcomes, especially when conventional therapies may not work for everyone. We owe it to patients to investigate various avenues, including repurposed drugs like Ivermectin, to find effective treatment protocols.
**Interviewer**: How do you see the future of Ivermectin research evolving?
**Dr. Makis**: I hope we will see more controlled studies being initiated both in the U.S. and internationally. Researchers should be encouraged to examine not just Ivermectin, but other existing medications that may offer new therapeutic options. The overall objective should always be improving patient care and ensuring that the best treatments are available.
**Interviewer**: Thank you, Dr. Makis, for sharing your insights with us. It’s clear that the conversation around Ivermectin is far from over.
**Dr. Makis**: Thank you for having me. It’s essential that we continue this dialog to ensure that we’re making informed decisions based on the best available evidence.
For those interested in the full details of this discussion, please refer to the complete interview available online [[1](https://yournews.com/2024/11/20/2888232/bombshell-interview-with-dr-william-makis-on-using-ivermectin-and/)].
